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Canine distemper virus (CDV) infection is a pantropic endemic and 
epidemic viral disease primarily of canidae and their close relatives. It 
is world-wide in distribution and .manifests itself as an acute contagious 
disease with clinical signs of respiratory, gastrointestinal, and/or 
nervous manifestations. 
Although the viral etiology was first demonstrated in 1905 (Carre, 
1905), significant advances in understanding the biology of the canine 
distemper virus were not made until the virus was adapted to grow first in 
embryonated eggs and later in tissue culture (Gorham , 1960; Appel and 
Gillespie, 1972). These advances permitted the development of serological 
assays for monitoring the disease process and p e rmitted the subsequent 
development of modified live vaccines. 
The safety of modified live virus vaccines has been a concern since 
their inception. When canine distemper is diagnosed in a recently 
vaccinated dog, there is concern as to whether the infection was the 
r€sult of a vaccine failure or a vaccine safety problem (Hartley, 1974; 
Krakowka et al., 1985; Cornwell et al., 1988). Some researchers (Krakowka 
et al., 1985) feel that the incidence of vaccine induced fatalit ies from 
canine distemper has increased in recent years because of the 
immunosuppressive effect of canine parvovirus. 
In this study, a comparison of vaccine and field strains of CDV was 
made. Biological markers were established that could be used to 
distinguish vaccine virus from field virus in dogs with c linical 
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distemper. In addition, techniques for the isolation and propagation of 
field viruses were compared. 
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LITERATURE REVIEW 
Physical Properties of Canine Distemper Virus 
Canine distemper virus is an enveloped virus in the genus 
Morbillivirus within the family Paramyxoviridae. Measles and rinderpest 
virus are also members of this same genus (Imagawa, 1968; Appel and 
Gillespie, 1972; Fraser and Martin, 1978) . The virus is a relatively 
large paramyxovirus and is composed of a pleomorphic envelope of host cell 
origin that surrounds an internal nucleic acid core. The virion varies 
from 100 to 300 nm in diameter. It is a single negative stranded RNA 
virus. The RNA has a molecular weight of approximately 6 X 106 daltons 
(Martin and ter Meulen , 1976). Smaller defective RNA molecules are also 
present, especially in virions obtained by the passage of undiluted virus 
(Carter et al., 1973; Kiley et al ., 1974; Underwood and Brown, 1974). 
Purified nucleocapsids of distemper contain 4-5% RNA (Waters and Bussell, 
1974). Several size classes of viral RNA, some corresponding to 
replicative and transcriptive intermediates, have been detected in nuclear 
or cytoplasmic fractions from cells infected with distemper (Martin and 
ter Meulen, 1976). The virus has been banded in cesium chloride and 
potassium tartrate. The mean buoyant density of the virion in these 
substances is 1.230 to 1.233 g/ml. 
The structure of the virus consists of six major polypeptides 
(Waterson et al., 1963; Waters and Bussell, 1973; Fraser and Martin, 1978; 
Hall et al., 1980; Rima, 1983). The nucleocapsid contains a single 
structural protein (NP) directly associated with the viral RNA. The size 
estimate for the NP protein of CDV is 58K (Campbell et al., 1980; Hall et 
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al., 1980; Orvell, 1980). A second core protein is associated with a 
phosphorylase enzyme and is known as the P protein. This protein is 
attached to the nucleocapsid and is a minor structural component with a 
molecular weight of 73K (Campbell et al., 1980; Hall et al . , 1980 ; Orvell, 
1980). The L protein, a very minor component of the virus, is the largest 
protein detected with a weight estimated to be between 160K and 200K. 
Stallcup et al. (1979) and Robbins et al. (198la) have found this protein 
to be associated with purified nucleocapsid but others have not detected 
it in this complex (Robbins and Bussell, 1979; Tyrell et al., 1980; 
Robbins et al., 198lb) . 
The hemagglutination protein (H) is the major gtycoprotein and can 
easily be detected as a 76K to 85K protein in CDV virions (Bussell et al ., 
1974; Campbell et al ., 1980; Orvell, 1980). The H protein is responsible 
for viral adsorption to target cells. The smaller glycoprotein, the 
fusion protein ( Fo), is a 41K unit which is rapidly degraded into two 
smaller subunits, a 27K Fl and a 14K F2. It is responsible for 
cell-to-cell fusion and is also referred to as the "fusion factor". The 
membrane or matrix protein (M) of CDV has been identified as the smallest 
virion protein with an apparent molecular weight of 34K (Campbell et al. , 
1980; Hall et al., 1980 ; Orvell , 1980) . Nonstructural proteins in 
morbillivirus-infected cells were discovered by Wechsler and Fields 
(1978). They identified 2 proteins migrating between the Hand P proteins 
of MV-in£ected cells. The functions of these proteins are not known. 
Measles virus has also been studied extensively and contains 
analagous viral polypeptides (Fraser and Martin, 1978). There are several 
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differences, however. The H protein of measles virus will hemagglutinate 
certain primate species' erythrocytes, whereas the H protein of CDV does 
not hemagglutinate erythrocytes from ariy species. Although these viruses 
are serologically cross-reactive, there is a difference in the reactivity 
of antibody to the hemagglutinin-equivalent protein. Anti CDV antibody 
will precipitate only CDV hemagglutinin-equivalent protein. In contrast, 
anti measles virus antibody will precipitate both CDV-H and MV-H 
polypeptides. 
Canine distemper virus is inactivated by heating for one hour at 
55° C or 30 minutes at 60° C. The virus is labile at pH 3.0 and relatively 
stable at pH 4.5 to 9.0 (Kimes and Bussell, 1968). Ultraviolet light and 
lipid solvents are known to readily inactivate the viral infectivity. 
Lyophilized virus is fairly stable at room temperature, but not above 
32° C (Piercy, 1961). The virus is stable to lyophilization; however, 
there is some loss of titer, usually about one log10 , during the 
lyophilization process. Virus is inactivated by formalin or the 
photodynamic action of methylene blue. Virtually all of the commonly 
employed chemodisinfectant substances such as quaternary ammonium 
compounds , phenolic compounds, and sodium hypochlorite will inactivate the 
virus meaning that decontamination of the environment is quite easy. 
Clinical Features of Canine Distemper 
Clinical signs of distemper vary depending on the virus strain, 
environmental conditions, host age, and immune status. It has been 
reported that more than 50 to 70% of CDV infections are subclinical 
(Greene, 1984). Mild forms of clinical illness are also common, with 
6 
signs including listlessness, d ecreased appetite, fever, and upper 
respiratory tract infections characterized by bilateral serous oculonasal 
discharge which can become mucopurulent, and by coughing and dyspnea. 
Severe generalized distemper infection is the commonly recognized 
form of t h e disease. It can occur in dogs of any age but most commonly 
affects puppies, 12 to 16 weeks of age, that have lost their mater nal 
antibodies or younger puppies that did not receive an adequate amount of 
maternal immunity. The initial febrile response in natural infections is 
usually unnoticed. The first sign of infection is a mild, 
serous - to-mucopurulent conjunctivitis, which is followed within a few days 
by a dry cough that rapidly becomes moist and productive. Lower 
respiratory sounds from the thorax increase and can be detected by 
auscultation. Depression and anorexia are followed by vomiting. Diarrhea 
subsequently develops, varying in consistency from brown fluid, to frank 
blood and mucous. Severe dehydration and emaciation can result·from 
adipsia and fluid loss. Animals can die suddenly from systemic illness, 
but adequate therapy in many cases can reduce the mortality rate. Many of 
the acute signs of systemic CDV infection are attributable to secondary 
and/or concurrent infection with various secondary bacterial, mycotic, and 
viral pathogens (Appel and Gillespie, 1972; Gorham, 1960). 
Neurologic signs of distemper i nfection usually begin 1 to 3 weeks 
after clinical signs begin to subside. Dogs can develop the neurologic 
signs without prior history of systemic disease, and there is no way to 
determine which animals will develop neurologic disorders . On an 
empirical basis, however, certain features of the systemic disease have 
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been described as being predictive of the incidence of neurologic 
sequelae . Pustular dermatitis in puppies is rarely associated with CNS 
disease, while dogs developing nasal and digital hyperkeratosis usually 
have various neurologic complications (Greene, 1984). 
Neurologic complications of canine distemper are the most significant 
factors concerning prognosis and recovery from infection. Neurologic 
signs vary according to the area of the CNS involved . Increased 
sensitivity to touch and cervical rigidity can be found as a result of 
meningeal inflammation. Seizures, cerebellar and vestibular signs, 
sensory ataxia , and myoclonus are also common. Seizures can be of any 
type, depending upon the region of the forebrain that is damaged by the 
virus. The "chewing gum" type of seizures, classically described for CDV 
infection, occurs in dogs developing polioencephalomalacia of the temporal 
lobes. However, lesions from other causes in the same region can produce 
similar seizures (Greene , 1984) . 
Pathogenesis 
The pathogenesis of canine distemper has been extensively studied, 
but certain features, such as the mechanism by which the virus produces 
encephalitis, are the center of current controversy. In natural exposure, 
the virus $preads between dogs by aerosol droplets and contacts epithelium 
of the upper respiratory tract. Within 24 hours, the virus replicates in 
tissue macrophages and spreads by local lymphatics to tonsils and 
bronchial lymph nodes (Appel, 1969). Following a local burst of virus 
production in these sites, the virus is then spread by lymphatics and 
blood to distant lymphoreticular tissues. This viremia occurs anywhere 
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from 2 to 4 days after initial infection. CDV-infected mononuclear cells 
are found in other lymphoid organs such as the bone marrow, thymus, and 
spleen . By days 4 to 6 post infection ; virus protein can be detected by 
fluorescent antibody staining within lymphoid follicles in the spleen, 
lamina propria of the stomach , small intestine, mesenteric lymph nodes, 
and Kupffer's cells in the liver. Widespread virus proliferation in 
lymphoid organs corresponds to an initial rise in body temperature and 
leukopenia . The leukopenia is primarily a lymphopenia, caused by viral 
damage to lymphoid tissues, affecting both T and B cells (Krakowka et al., 
1980) . 
Further spread of CDV to epithelial and CNS tissues on days 8 to 9 
.post in£ection probably occurs hematogenously as a cell-associated and 
plasma phase viremia and depends on the dog's humoral and cell-mediated 
immune status. Fourteen day s after infection, animals with distemper 
virus antibody titers of greater than 1:100 clear the virus from most 
tissues and show no clinical signs (Appel, 1969; Appel et al., 1982). In 
vitro, specific CDV antibody has been effective in neutralizing 
extracellular CDV antibody as well as in inhibiting its intercellular 
spread (Ho and Babiuk , 1979a). 
Dogs with delayed production of antibody undergo virus spread to 
epithelial tissues 9 to 14 days after infection. Clinical signs that 
develop may eventually resolve as antibody titers increase and virus is 
cleared from most body tissues. However, virus may persist in neurons and 
integument, such as foot pads, for extended periods . Spread and 
persistence of virus in these tissues may be responsible for delayed CNS 
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signs and digital hyperke ratosis (hard pads) that occur in some dogs 
(Greene , 1984). 
Dogs with poor i mmune response undergo v irus spread to many t issues 
by days 9 to 14 post i nfection . These tissues include skin, exocrine and 
endocrine glands , and epithelium of the gastrointestinal, respiratory, and 
genitourinary systems. The clinical signs in these dogs are dramatic and 
severe, and virus persists in their tissues until death. 
Neurological forms of CDV infection can be divided into a cute or 
chronic encephalitis. The acute form is charac terized by virtually any 
combination of neurological signs but most commonly seen a r e petit mal or 
grand mal seizures. These convulsive episodes occur with increasing 
frequency over time. The neurological signs in these cases include 
disorders attributable to cranial nerve damage, meningitis, and signs 
attributable to diffuse cerebral disease, i.e., confusion and head 
pressing. A cerebellar form in which incoordination and instability may 
be seen, and a spinal cord form in which paralysis or paresis is a 
predominant sign , may also occur. Some dogs are photophobic and a few may 
become blind because of GOV-induced r etinal and optic nerve damage . A 
characteristic neurologic sign is hyperkinesia or chorea which may persist 
into convalescence. 
The chronic form of encephalitis associated with canine dis temper 
occurs after apparent recovery from infection . Chronic encephalitis is 
characterized histopathologically by severe and nonselective demyelination 
and perivascular mononuc l ear cell infiltration. As with acute CDV 
encephalitis, the pathogenesis of demyelination in the chronic form is not 
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understood. The effect of antimyelin antibodies h as recently been studied 
in dogs wi t h chronic encephalitis, and they may induce or contribute to 
the demyelination process (Krakowka et al., 1973; Krakowka et al., 1981 ; 
Koestner et al. , 1974; Vandevelde et al., 1982a). The CNS signs can be 
extremely varied and are difficult to diagnose as attributable to CDV 
infection without histopathologic examination. The r easons for this are 
t he dogs are no longer viremic and the isolation of the virus in 
leukocytes, excretions, or secretions is not possible. Dogs affected with 
chronic encephalitis us ually have increased CDV-specific antibody in the 
cerebral spinal fluid and serum. Specific immunoglobulin can be 
demonstrated both intracellularly and extracellularly within l es ions in 
the CNS (Krakowka and Koestner, 1976; Vandevelde et al., 198 1, 1982a , 
1982b). 
A major nonneural manifestation of CDV infection in dogs is 
GOV-associated immunosuppression characterized by depletion of T and B 
lymphocytes (Krakowka et al., 1975; Krakowka et al., 1980) . In animals 
with secondary bacterial or viral infections, normally . nonpathogenic 
organisms may become lethal due to the immunosuppression i nduced by CDV. 
The most likely mechanism that permits infection by secondary invading 
organisms is via a direct or indirect viral effect on the host immune 
system. This immunomodulating effect is a significant and important 
component of the disease. Lymphopenia has been noted as a he matological 
finding (McCullough et al., 1974) , and CDV associated i mmunos uppression 
has been documented using a variety of in vitro and in vivo assays 
(Krakowka et al. , 1975; Krakowka et al., 1980; Krakowka, 1982) . 
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As a consequence of direct viral infection in either lymphoid cells 
and/or macrophages, lymphocytes from CDV-infected dogs are rendered 
incapable of producing effective in vitro and in vivo immune responses. 
Early virolytic effects of CDV on the lymphoid system and macrophages 
suppress established normal host defenses. Immunosuppression is not 
simply due to a direct virolytic effect, since immunosuppression persists 
long after virus can no longer be readily demonstrated ih lymphoreticular 
tissues (Krakowka et al., 1975). 
Although attenuated vaccine viruses have not been shown to be 
immunosuppressive to the same degree (Schultz, 1976), Potgieter 
et al. (1980) reported the occurrence of enteritis and neutropenia in 3 of 
3 dogs given canine parvovirus (CPV) one week after being vaccinated with 
canine distemper and infectious canine hepatitis vaccine; one dog died. 
Dogs given CPV but not vaccinated previously with the combination vaccine 
remained well. The reverse situation has also occurred when dogs given 
distemper vaccine while ill with presumed CPV enteritis have subsequently 
died with confirmed distemper (Jezyk, 1980). 
A controversy exists concerning the immunosuppressive effects seen 
with multivalent canine vaccines containing both CDV and CPV. Ritter 
(198~a, 1983b) posed the question of possible safety problems with 
vaccine-induced CD due to immunosuppression caused by CPV contained in 
combination modified live-virus (MLV) vaccine. He stated that the 
combined vaccine induced lymphopenia at day 5-7 post vaccination. Gill 
(1983) and Beckenhauer (1983) contradicted this statement by reporting 
that lymphocyte counts did not drop after vaccination with parvovirus 
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alone or declined slightly but remained within the normal range. Their 
conclusion was drawn from a study involving a total of 3 test animals. In 
testing conducted in over 20 dogs at the National Veterinary Services 
Laboratories, canine origin parvovirus vaccines routinely caused a 
lymphopenia after vaccination (Evans, 1982 ). 
Species Susceptibility 
Canine distemper virus is an infectious disease of several members of 
the order Carnivora. A number of families have been shown to be 
susceptible to CDV, and prominent among them are the Canidae such as dogs, 
dingos, and foxes; the Procyonidae which inc ludes raccoons, kinkajous, and 
lesser pandas; the Mustelidae which includes ferrets, mink, skunks, and 
badgers; and the Hyaenidae which includes the hyena (Krakowka et al., 
1985 ). 
No adequately documented case of naturally acquired infection wi th 
CDV in cats has been published. Experimentally , newborns, 6 to 8 -week-old 
kittens , a~d adult cats were infected wi t h the Snyder Hill strain (Appel 
et al .• 1974). The cats experienced limited replication of the virus, but 
did not develop clinical disease nor was virus shed. The authors 
concluded that the cat is unlikely to be affecte d with CDV under natural 
conditions. An inclusion body encephalitis a ttributed to CDV was 
described in tigers (Gould and Fenner, 1983; Blythe et al., 1983). 
Although distemper virus was not isolated from these animals, at least one 
animal showed a rising titer to CDV during infection. Formalin-fixed 
brain tissue from both animals stained positive for CDV antigen using an 
indirect immunofluorescence procedure (Krakowka et al ., 1985). 
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Of the common laboratory animal species, the most work has been done 
in mice with murine-adapted CDV (Appel and Gillespie, 1972; Gorham, 1960). 
Adaptation of virus to mice is best accomplished by serial intracerebral 
inoculation of suckling mice with viral suspensions (Gilden et al., 1981). 
In most cases, the infection is characterized as a monophasic acute 
encephalopathy with mild meningitis and focal to multifocal areas or 
confluent zones of necrosis within the brain (Gilden et al., 1981). This 
phenomenon is age-dependent and adult mice seem to be resistant to 
replication of even murine-adapted virus, whereas weanling mice show an 
intermediate pattern of clinical disease (Lyons et al., 1980). 
Approximately 40% of weanling mice inoculated with murine passaged-GOV die 
acutely . The remaining convalescent animals may live for long periods of 
time. The consequences of this infection are a neurologic syndrome and an 
obesity syndrome in surviving affected animals (Bernard et al., 1983; 
Lyons et al., 1982). The strain of mice influenced the severity of 
disease and resistant strains of weanling mice developed a slowly evolving 
encephalitis at 13 to 17 months post - infection rather than the acute 
fulminant form noted in susceptible strains of mice (Bernard et al., 
1983). 
In hamsters, the neurovirulence potential is dependent on the plaque 
type of the virus. Cosby et al. (1981) have inoculated the large and 
small plaque variants of the Onderstepoort strain CD virus into hamsters 
and have shown that the small plaque variant of tissue culture-adapted CDV 
is neurovirulent for the hamster, whereas the large plaque variant is not. 
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Since CDV is closely related to MV, it has been suggested that CDV 
may be infectious for primates. It is known that primates are susceptible 
to experimental inoculation with virulent CDV (Yamanouchi et al., 1977) 
and that central nervous system lesions produced mimicked those caused by 
MV infection in either primates or man. It has been suggested that CDV is 
involved in the etiology of multiple sclerosis (MS), a debilitating 
central nervous system demyelinating disease . However, serological and 
epidemiologic studies have not supported this hypothesis (Cook and 
Dowling , 1977; Appel et al . , 1981; Burridge, 1978). Canine distemper virus 
has never been recovered from patients with MS. 
Virus Cultivation In Vitro 
Canine distemper virus is a difficult virus to propagate in vitro. 
However, once the virus is adapted to tissue culture, it can be 
transmitted further to other cell culture systems, and readily propagated 
thereafter (Cabasso et al., 1959; Rockborn, 1958) . The most reliable 
method for in vitro growth of virulent CDV is by use of a macrophage 
system . Appel and colleagues have shown that virulent virus will readily 
infect primary cultures of canine pulmonary macrophages (Appel and Jones, 
1967). Similar findings were reported using ferret origin peritoneal 
macrophage cultures (Whetstone et al .• 1981) . The easiest way to transfer 
infection from macrophages to other cells is by performing co-cultivations 
of infected cultures with standard tissue culture cell lines (Confer et 
al., 1975a; Bui et al., 1982). A second cell culture type shown to be 
susceptible to virulent virus inoculation is a bovine proliferative cell 
culture system reported by Metzler et al. (1980a, 1980b, 1981). They 
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showed that inoculation of bovine fibroblastic cells obtained from long 
term cultures of peripheral blood macrophages with tissue suspensions 
containing virulent CDV resulted in the recovery of virulent virus from a 
persistent noncytolytic infection within the fibroblastic cells. 
Subsequent study has shown that virus from these bovine fibroblast 
cultures could be transferred to other continuous cell lines by 
co-cultivation methods (Confer et al., 1975a). A third culture system, 
primary canine bladder epithelium , has also been used to isolate virulent 
CDV (Bui et al., 1982) . 
Canine distemper virus has been propagate d in many different cell 
culture systems including cells of avian, mustelid, canine, human, feline, 
and simian origin (Appel and Gillespie, 1972) . Virus readily adsorbs to 
target cell monolayers. Peak adsorption occurs within 1 hour and is 
essentially complete by 4 hours ( Appel and Gillespie, 1972). 
Investigators have shown that free infectious virus is released into the 
supernatant between 24 to 36 hours after inoculation (Confer et al., 
1975a) . Peak viral titers in supernatants are generally observed between 
3 to 5 days after infection. 
Canine distemper v i rus can produce cytopathic effects (CPE) when 
inoculated onto several lines of cultured cells. The most obvious CPE is 
the formation of multinucleated giant cells where fusion is mediated 
between adjacent infected cells by the envelope membrane associated Fo 
protein. Coincident with the formation of giant cells is the appearance 
of intracytoplasmic and intranuclear eosinophilic inclusion bodies 
(Krakowka et al ., 1985 ). These inclusion bodies can be easily seen when 
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the culture monolayers are stained with hematoxylin and eosin. 
Accompanying syncytia formation, the host cells form cytoplasmic strands 
and eventually lyse. Viral cytopathology is more obvious and more 
dramatic in young, actively growing cell cultures. The extent and 
duration of viral CPE depends on the composition of the original viral 
inoculum. For example viral fluids have been shown to contain more than 
one plaque type (Krakowka et al., 1985), and the ratio of the plaque types 
may affect overall CPE. Plaque variants can affect the size of the 
multinucleated giant cell produced. 
There are viral variants of CDV that replicate without an overt viral 
CPE leading to a persistent infection (Metzler et al ., 1980b; ter Meulen 
and Carter, 1982; ter Meulen and Martin, 1976; Narang, 1982; Krakowka et 
al., 1985). Persistently infected cells will contain cytoplasmic and in 
some instances, nuclear inclusion bodies, but monolayers will lack other 
manifestations of viral CPE. The morphological appearance and growth 
characteristics for these infected cells are virtually identical to those 
in uninfected control cultures . 
Vaccination 
Immunity to CDV infection is considered long term, and lasting 
immunity and immunologic homogeneity of the virus have made disease 
prevention possible through vaccination . Humoral immunity is involved in 
host defenses since passive administration of serum antibody has been 
beneficial in preventing distemper (Peacock, 1966). Passively 
administered globulin was used extensively prior to the development of 
effective vaccines, but inadequate standardization of potency and 
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interference with modified live virus vaccines contraindicated its 
continued use. Naturally acquired passive i mmunity blocks both infection 
and adequate immunization in the early ~ost partum period (Appel and 
Gillespie, 1972; Gorham, 1960). Three per cent of antibody transfer 
occurs in utero and 97% in the colostrum, resulting in an initial titer in 
new pups that is usually equal to 77% of that in the bitch. Maternal 
antibody to distemper has a half-life of 8.4 days, and typically these 
antibodies will decline to below detectable levels by 10-12 weeks of age 
(Gillespie et al., 1958; Baker et al., 1959). Without the ingestion of 
colostrum, offspring of immune bitches with titers of from 200-500 are 
protected for approximately one week (Appel and Gillespie, 1972). Bitches 
with titers of greater than 1 : 1000 may pas~ on proportionately more 
antibodies in utero, protecting colostrum-deprived puppies from CDV 
infection for 3 to 4 weeks (Krakowka et al., 1978) . 
Puppies vaccinated with MLV vaccine cannot produce appropr,iate immune 
responses until maternal antibody decreases below a level of 1:20 (Baker 
et al., 1959). Antibody measurements have been made in puppies to 
determine the age at which they can be successfully immunized. This 
information has been used to create nomograms based on the bitch's titer 
that can be used to pre dict the optimal time of vaccination in puppies. 
Pups with a maternal antibody titer of 1:100 are considered resistant to 
disease and immunization with MLV vaccines is futile. For this reason, 
initial vaccination with CD vaccine may not induce a protective antibody 
titer, and a second and sometimes third vaccination at 3 to 4 week 
intervals is r ecommended to produce a lasting serum antibody 
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concentration. Yearly boosters are recommended for this disease despite 
the relatively long-lived immunity afforded by vaccination. 
Vaccines produced for canine distemper have been continually improved 
with respect to level and duration of immunity . The first inactivated 
vaccines were used in the 1920s and were derived from virus-infected 
ferret tissue homogenates that were inactivated with formalin (Laidlaw and 
Dunkin, 1928) . These vaccines produced poor immunity in dogs, required 
multiple injections, and caused tissue reactions because of the presence 
of foreign protein. Ott et al . (1959) developed an adjuvanted formalin 
inactivated vaccine which produced higher antibody titers than the non-
adjuvanted vaccine after 2 or 3 vaccinations, but i~unity did not last 
longer than 3 months . 
The development of a ferret - passaged live virus for the control of 
distemper in foxes and dogs was first reported by Watson (1939). Ferret 
passaging was the first method used to attenuate the virus, and the first 
commercially available MLV vaccine was Green's Distemperoid (Green and 
Swale, 1939). Only partial attenuation was achieved, and clinical signs 
were sometimes not~d 1 to 2 weeks after vaccination. Haig adapted Green's 
ferret origin distemper virus to the avian chorioallantoic membrane and, 
after further attenuation on these membranes, produced the Onderstepoort 
vaccine strain of canine distemper virus vaccine (Haig, 1948). Cabasso 
and Cox successfully adapted a field distemper virus to the egg, and 
introduced the Lederle strain of egg-adapted distemper virus vaccine 
(Cabasso and Cox, 1949) . This strain was introduced as the first modified 
live egg-cultivated vaccine. Following vaccination, egg adapted MLV 
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multiplies transiently in the lymphoid system, generating an immune 
response. The virus is not spread to epithelial tissues and virus 
excretion does not occur (Krakowka and Koestner, 1976). For this reason, 
vaccine-induced immunity with this type of virus is never as great or as 
long-lasting as the immune response occurring after natural exposure. 
Distemper virus was adapted to cell culture in the late 1950s through 
the work of Rockborn (1958), Cabasso et al., (1959), Vantsis (1959), and 
others. By 1960, the first cell culture origin distemper vaccines were 
introduced (Sinha et al., 1960; York et al., 1960; Baker, 1966). The 
newer cell culture products produce immunity in a similar manner to that 
of the egg-adapted MLV products, but also have the advantage of containing 
~ess foreign antigenic material while being more immunogenic. They also 
protect dogs at an earlier age, even in the presence of high maternal 
antibody titers (Kahn and Rubie, 1979). 
Canine distemper and human measles viruses are antigenically related, 
and experimental infection of dogs with measles virus protected them from 
subsequent infection with CDV (Gillespie and Karzon, 1960). Measles 
vaccine virus produces a self-limiting infection in the lymphoid system of 
dogs similar to that of MLV-CDV vaccines (Greene , 1984). Measles 
vaccination offers the advantage of protection in young puppies with high 
concentrations of maternal antibodies to distemper (Wilson et al., 1974, 
Wilson et al . , 1976). As mentioned previously , the measles vaccine virus 
can stimulate an immune response in the presence of CD antibodies. 
Cell-mediated immunity induced by the measles virus is thought to be the 
primary factor involved in the protective response (Brown, 1975; Gerber 
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and Marron 1976; Krakowka et al., 1978). In addition, cross-reacting 
antibody, viral interference, and interferon mechanisms may be involved 
(Ho and Babiuk, 1979b) . 
Immunity to distemper acquired from measles vaccination is not only 
transient but weaker than that derived from a successful vaccination with 
MLV distemper vaccine (Strating, 1975; Norrby and Appel, 1980). Comparison 
of distemper-vaccinated and measles-vaccinated dogs shows that the latter 
are not as well protected against aerosol challenge. These dogs develop 
the initial febrile response but do not exhibit the diphasic temperature 
response or other clinical signs typical of CD infection (Ott, 1970; 
Strating, 1975). Dogs vaccinated with MV are not protected when 
challenged intracerebrally with virulent distemper virus although MLV-CD 
vaccines will routinely protect against challenge by this route (Standard 
Requirements, 1974). 
Biological Markers of Virulence 
The spread of canine distemper virus is associated with the infection 
of macrophages (Coffin and Liu, 1957; Cornwell et al., 1965) which act to 
disseminate virus in the early stages of infection. Poste (1971) 
described differences in the growth of virulent and attenuated strains of 
CDV in alveolar and peritoneal macrophages from both dogs and ferrets. 
The virulent strain was from a field case, but it was used at two passage 
levels. The first passage level was after adaptation to growth in canine 
cells. The second passage level was after additional adaptation to ferret 
cell culture. The attenuated strain was a vaccine strain (designated 
CDV/BW) that was capable of growth in both dog and ferret cell cultures. 
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Poste noted that while the two passage levels of the virulent strain and 
the attenuated strain grew in all macrophage types, the CPE produced by 
the virulent strains were unique in alveolar macrophages. In these cells, 
the nuclei in the polykaryocytes were arranged randomly and many of the 
nuclei were high ly pleomorphic and grossly distorted. Most of the 
polykaryocytes contained nuclei of widely different sizes 
(anisokaryocytosis). The distribution of the chromosomes in the infected 
cells were abnormal with evidence of chromosomal fragmentation or 
pulverization. Although the attenuated strain grew to comparable titers 
in alveolar macrophages, similar nuclear damages was not detected with the 
vaccine strain. 
Replication of the dog kidney cell adapted Rockborn vaccine strain of 
CDV in dog alveolar macrophages was examined by Appel (1978). He noted 
that by serially passaging the virus in dogs (intravenous inoculation 
followed by isolation of the virus from cervical lymph nodes surgically 
removed 5 days later) the virus increased in virulence. Accompanying this 
increase in virulence was a shift in the relative abiLity of the virus to 
grow i n alveolar macrophages versus canine kidney cells. The avirulent 
virus grew well in kidney cells but poorly in macrophages while the 
virulent virus grew well in macrophages but poorly in kidney cells. Appel 
assumed that a virus population of increased virulence emerged during 
passage in dogs and this population, which preferentially replicated 
better in macrophages, overcame the attenuated virus population which grew 
better in kidney cells . He stated that virulence in CDV appears to be 
linked to the ability of virus to infect and replicate in dog macrophages, 
22 
but the Rockborn strain was the only one studied. Appel did not address 
any differences in nuclear cytopathology between the virulent and 
attenuated passage levels of the Rockborn strain. 
The relative titers obtainable in chicken embryos, dog kidney cells, 
Vero cells, and ferret peritoneal macrophages were determined by Whetstone 
et al. (1981) for 8 isolates from vaccines and 2 preparations of the 
virulent Snyder Hill strain. The nontissue culture and nonegg adapted 
virulent Snyder Hill strain grew better in ferret macrophages than in the 
other systems tested. However, there was no appreciable difference in the 
titers of the attenuated strains obtained in macrophages compared to the 
titers obtained in the system to which they were adapted except for the 
~ero adapted Lederle strain and chicken fibroblast adapted Baker strain 
which titered higher in ferret peritoneal macrophages. In no instance did 
a vaccine strain demonstrate a higher infectivity in the kidney cell 
cultures than in macrophages. This observation contradicts the findings 
of Appel (1978), but peritoneal macrophages were used in the study by 
Whetstone et al. (1981), and alveolar macrophages were used in the study 
by Appel (1978). This difference in the source of macrophages may be 
important since Paste (1971) only noted differences in nuclear 
cytopathology with virulent strains in alveolar and not peritoneal 
macrophages. The cytopathology seen with the strains in the various 
tissue culture systems was not described in detail by Whetstone et al. 
(1981). The authors concluded that ferret peritoneal macrophages were an 
acceptable alternative to canine alveolar macrophages for the isolation of 
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virulent CDV, but the Snyder Hill strain was the only strain utilized in 
the study. 
Confer et al. (197Sa) demonstrated differences between virulent and 
attenuated CDV strains by their relative ability to grow in cell cultures . 
They found that after the virulent R252 and Snyder Hill strains were 
adapted to grow in Vero cells by subpassaging 5 times, the strains 
produced eosinophilic nuclear inclusions 7 days postinfection in Vero 
cells stained with May Grunwald-Giemsa stain . Distinct fluorescent 
nuclear bodies were also seen with the virulent strains in cells stained 7 
days postinfection with fluorescence labeled CDV antibody. In a later 
study (Confer et al ., 1975b), the nuclear bodies were examined by electron 
microscopy and found to be aggregates of nucleocapsid-like structures. 
The only attenuated strain examined was the Onderstepoort strain, and 
although it produced polykaryocytes and exhibited cytoplasmic fluorescence 
t hat was typical of those seen with the virulent strains, it did not 
produce nuclear inclusions or fluorescing nuclear bodies. Nuclear 
aggregates were also not observed when the cells were examined electron 
microscopically (Confer~ gl . , 1975b). This study and the one with 
alveolar macrophages (Poste, 1971) indicate that nuclear cytopathology and 
not the permissiveness of cells for viral replication, may be a mar ker for 
virulence. 
In other studies conducted with CDV in Vero cells, Cosby 
et al. (1981 , 1983) found that the Onderstepoort strain produced both 
large and small plaques on Vero cells. By picking plaques of different 
sizes, they were able to obtain cultures that would produce either large 
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or small plaques exclusively. Weanling hamsters inoculated 
intracerebrally with the large plaque virus developed an acute 
neurological illness characterized by ataxia, convulsions, and paralysis 
typical of an acute encephalitis . Animals inoculated with the small 
plaque virus failed to produce any clinical signs of illness for the first 
3 months postinoculation but did develop a general deterioration in 
condition characterized by weight loss and increased susceptibility to 
infection over the next 9 months. Differences in the nuclear 
cytopathology caused by the 2 isolates were not described, and the 
neurovirulence for animals othe r than hamsters was no t investigated by the 
authors. 
Hirayama et al. (1986) compared the biological and molecular 
properties of 7 attenuated and 3 virulent strains of CDV. They found tha t 
all the strains would produce plaques in Vero cells, but while the mean 
diameters of the plaques were reported and varied with the strains, the 
authors did not state if both large or small plaques we r e observed . Four 
of the 7 attenuated strains had me an plaque sizes of >.0 . 7 mm, and these 
strains were the only ones that we r e neurovirulent ·in suckling mice . Of 
the three attenuated strains and three virulent strains that had a mean 
plaque size of 0.4 mm, only the Onderstepoort strain was neurovirulent in 
suckling mice . 
'While Hirayama et a l . ( 1986) felt that a correlation between plaque 
size in Vero cells and neurovirulence in mice was suggested by the data , 
they believed that the capacity of the strains to form pocks on the 
chorioallantoic membrane (CAM) of 7- day-old chicken embryos was a better 
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indicator of virulence in dogs. All the virulent strains showed low 
pock-forming capacity compared to relatively high capacities for the 
attenuated strains. However, all the vaccine strains had been passaged at 
least 40 times in eggs and the virulent strains had never been passaged in 
eggs. 
Molecular Markers of Virulence 
Cosby et al . (1981) demonstrated that a large plaque variant of the 
Onderstepoort vaccine strain of CDV was virulent for hamsters when 
inoculated intracerebrally while a small plaque variant was not. 
Polyacrylamide gel electrophoresis of radiolabeled polypeptides and 
glycoproteins indicated no difference in the size of the proteins produced 
from persistent cultures of the large and small plaque variants. In a 
similar study, Axthelm et .21. (1987) could not detect differences in viral 
proteins from a ferret virulent strain and a ferret avirulent strain of 
CDV. The proteins were separated by polyacrylamide gel electrophoresis 
and stained by the Western (immunoblot) technique. 
Differences in viral proteins produced by the Onderstepoort strain, a 
strain isolated from a dog with chronic encephalitis, and two strains 
isolated from dogs with old dog encephalitis were investigated by Shapshak 
et al. (1982). They noted that the nucleocapsid protein (NP) of the 
strains isolated from dogs with chronic neurological disease were of a 
lower molecular weight than the NP from the Onderstepoort strain. 
One-dimensional peptide maps following protease digestion demonstrated a 
unique pattern for the Onderstepoort strain and for the strain from the 
dog with chronic encephalitis. The patterns for the 2 strains causing old 
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dog encephalitis were the same. Differe nces were also observed in peptide 
maps obtained with the H, Fo, and Fl polypeptides but the differences did 
not correlate with virulence. No differences were seen in the digests of 
the M polypeptide . 
In contrast to the higher molecular we ight of the NP protein of the 
Onderstepoort strain reported by Shapshak et al. (1982), Hirayama et al. 
(1986) could not detect any appreciable differences in the molecular 
weights of the viral proteins from 7 avirulent strains (including 
Onderstepoort) and 3 virulent strains . The slight differences in 
electrophoretic mobility that were noted among the strains did not 
correlate with virulence. 
Differences in the NP, P, F , and H proteins of the Gonvac, 
Onderstepoort, and Rockborn vaccine strains of GOV were evaluated by 
Orvell et al. (1985) with the use of 149 monoclonal antibodies. Each 
strain had a few unique antigenic sites. Variation was found in four, 
one, and three different antigenic sites of the NP, P, and H proteins 
respectively . No antigenic differences could be demonstrated between the 
three attenuated strains of GOV using· t he 10 monoclonal antibodies that 
reacted to the F protein. 
Varsanyi et a l . (1987) sequenced the Fl protein of the Onderstepoort 
and Gonvac vaccine strains of GOV. The two sequences were identical at 
the N-terminal region except for one amino acid. The sequence showed a 
high degree of homology with the previous l y determined N-terminal sequence 
of the Fl polypeptide of measles vi rus (Varsanyi et al., 1985) and 
moderate homology with the c orresponding sequence of 5 other 
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paramyxoviruses (Richardson et al., 1980 ; Hsu and Ghoppin, 1984 ; Blumberg 




Based on the previous studies, it is unlikely that the analysis of 
the molecular weights of the proteins of CDV will reveal differences that 
can be correlated to virulence. Complex studies that have u tilized 
monoclonal r eactivities and protein digest mapping have demonstrated 
considerable variation among the vaccine strains indicating that a marker 
common to all vaccine or all field strains would be difficult to 
determine. Sequencing of the fusion protein, the most likely source of a 
virulence marker, has indicated a high degree of conservatism in this 
protein for different GOV strains and for paramyxoviruses as a whole. 
Because of the unlikelihood of finding a molecular marker of virul ence by 
existing techniques, this project concentrated on the confl icting findings 
on biological markers to determine which markers, if any, a r e consistent 
with a large sampling of field and vaccine strains of CDV. 
This study examined three biological properties of CDV to determine 
if any of the three will consistentl y differentiate field from vaccine 
strains . These included: (1) comparison of the ability of the strains to 
infect macrophages and epithelial cells; (2) evidence of significant 
cytopathologic effect in alveolar and peritoneal macrophages and Vero 
cells; and (3) the ability of the strains to produce pocks on t he 
chorioallantoic membrane of chicken eggs. 
Four vaccine strains and S field strains of CDV were used in the 
experiment. Four of the S field strains were isolated from clinical cases 
of canine distemper. The fifth isolate was from a dog showing signs of 
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old dog encephalitis. None of the field strain s had been pas saged in 
tissue culture. 
Evidence of cytopathology including giant cell formation in canine 
alveolar and ferret peritoneal macrophages and intranuclear inc lusion 
bodies in Vero cells were d etermine d b y staining the cells with May 
Grunwald-Giemsa stain at 7 days post inoculation. In addition, the field 
isolates of CD were also titered in ferret alveolar macrophages to 
determine the most susceptible cell for virus isolation. Titer 
comparisons of strains in macrophages, Vero cells, and prima r y canine 
kidney cells were determined by the fluorescent antibody technique. In 
eggs, the i noculation of the c horioallantoic membran~s of chick embryos 
was used to determine the pock forming titer of the CDV strains. 
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MATERIALS AND METHODS 
Viruses 
Four canine distemper virus strains used in the study were obtained 
from commercially available vaccines. They included a canine kidney cell 
line origin Rockborn strain, an African green monkey kidney cell line 
(Vero) origin Lederle strain, a chicken fibroblast origin (CFO) Lederle 
strain , and a canine kidney cell line origin Snyder Hill strain. The 
actual source of t he vaccine viruses will not be given because of the 
possibility of disclosing proprietary information. Five field isolates 
used in the study were obtained directly from dogs. They included the 
Snyder Hill-NVSL strain1 in a 20% canine brain suspension and A75-17, 
A76-9, and A76-21 strains in canine lymphatic tissue suspensions2 obtained 
from dogs with clinical distemper . The fifth virus was strain A76-30 in a 
canine lymphatic tissue suspension isolated from a case of old dog 
encephalitis. 2 This information is summarized in Table 1 . 
The vaccine viruses were isolated from multivalent vaccines by 
blocking the other viruses with the appropriate antisera and then 
culturing in primary canine kidney cells (Rockborn strain), a canine 
kidney cell line (Snyder Hill strain), or Vero cells (Lederle strains) for 
8 days. After freezing and thawing once, the viruses were dispensed and 
titrated in the tissue culture systems described below. They were also 
tested for extraneous canine adenovirus and canine parainfluenza virus by 
neutralizing the canine distemper virus with monospecific antiserum and 
Obtained from T. 0. Bunn, Ames, Iowa . 
2 Obtained from M. J. G. Appel, Ithaca , New York. 
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Table 1. Canine distemper virus strains 
Strain Source Substrate 
Rockborn Vaccine Canine kidney cell 
Snyder Hill Vaccine Canine kidney cell 
Leder le Vaccine Vero cell 
Leder le Vaccine Chicken fibroblast 
Snyder Hill-NVSL Field Canine nervous tissue 
A75- 17 Field Canine lymphatic tissue 
A76-9 Field Canine lymphatic tissue 
A76-21 Field Canine lymphatic tissue 
A76 -30 Field3 Canine lymphatic tissue 
8 0btained from a case of old dog encephalitis. 
32 
inoculating the virus-serum mixture onto primary canine kidney cells. The 
cells were examined for cytopathogenic effect at 10 days. All cultures 
were negative for extraneous vaccine vfruses. 
Replication in Tissue Culture 
The ability of the CD strains to replicate in various culture systems 
was determined by culturing the viruses in primary canine kidney cells, 
Vero cells, ferret peritoneal macrophages, and canine alveolar 
macrophages . 
Kidney cells 
The primary canine kidney cells and Vero cells ~ere trypsinized from 
stationary 150 cm2 tissue culture flasks and planted onto 8- chamber slides 1 
for the detection of virus growth by the fluorescent antibody technique. 
Cells were planted at 150 ,000 cells/ml, 0.4 ml/well, and inoculated the 
same day as planted with 0.1 ml of virus per well. 
The medium used for all tissue culture procedures was Eagle's minimum 
essential medium with Earle's salts, L-glutamine, and nonessential amino 
acids . 2 Seven percent fetal bovine serum (FBS ), gentamicin (25 mcg/ ml), 
penicillin (25 IU/ml), and streptomycin (100 mcg/ml) were added . The same 
medium, without fetal bovine serum, was used as diluent in all virus 
titration procedures. 
1 Lab-Tek Products , Naperville, Illinois. 
2 F-15, Grand Island Biological Company, Grand Island, N. Y. 
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Macrophages 
Ferret peritoneal macrophages were collected afte r inoculating a 
ferret with 3 ml of sterile mineral oil. intraperitoneally 4 days prior to 
harvest. At day 4, the animal was anaesthetized with 0.75 ml ketamine 
hydrochloride , 1 and the ventral abdomen was shaved and c leansed . 
Approximately 200 ml of the medium described above (without FBS) and 
containing 10 units/ ml heparin were then injected into the peritoneal 
cavity at a point on the midline and about 5 cm below the sternum . 
The abdomen was massaged for one minute, and the fluid was removed 
under suction with a 14-gauge catheter attached to a 60 ml syringe. The 
catheter was inserted into the peritoneal cavity at a point on the 
poste rior abdomen lateral to t h e midline. Of the 200 ml of medium 
injected, approximately 150 ml were retrieved. The cell suspension was 
then centrifuged at 200 x g for 10 minutes. The supernatant was decanted, 
and the packed cells obtained from one ferret were resuspended into 40 ml 
of tissue culture medium wi th 15% FBS to obtain a concentra t ion of between 
2 and 4 x 106 cel l s/ml . The macrophages were planted into 8-chamber 
slides, 0 . 4 ml/ well, and incubated at 37° C in a 5% C02 atmosphere. At 24 
hours, the medium was changed and the slides were inoculated with 0. 1 
ml/well of CD virus. 
Canine alveolar macrophages were collected from dogs euthanatized 
with T-61 .2 The thoracic cavity was opened and t he lungs and trachea 
Ketaset, Bristol Laboratories Inc., Syr acuse, New York. 
2 National Laboratories Corp., Somerville, New Jersey. 
34 
removed. A 14-gauge cannula was inserted into a major bronchus of the dog 
and secured with string. Sixty mi lliliters of tissue culture medium were 
injected into the lungs and remove d with a 60 ml syringe . This lavage 
procedure was performed twic e . 
The cell suspension obtained was then centrifuged at 200 x g for 10 
minutes. The supernatant was decanted and the packed cells resuspended at 
106 cells/ml with tissue culture medium containing 15% FBS. The 
macrophages were planted onto 8-chamber slides, 0.4 ml/ well and incubated 
at 37° C in a 5% C02 atmosphere . At 24 hours , the medium was changed and 
the slides were inoculate d with 0.1 ml / well of virus. 
Virus ~ssay in tissue cul t ure 
Each cell type used was inoculated with ten-fold dilutions of each 
virus, 10-1 through 104 , 4 wells/ dilution . The chamber slides were then 
incubated at 37° C in a 5% co2 atmosphere for 6 days. At the conclusion of 
the incubation period , the slides were fixed in acetone and stained with 
fluorescein tagged canine origin canine distemper conjugate. Cells were 
examined for typical fluorescence using an Orthoplan1 microscope equipped 
with a 200-watt mercury light source and an incident-light illuminator . 
Each well that containe d at least one fluores c ing cell was considered 
positive, and virus titers were determined by the Spearman-Karber method 
as refined by Finney (1971) . Using this s ystem, the lowest detectable 
titer was 1. 7 log10 TCID50 / ml (1 of 4 wells positive at t he 10-
1 dilution). 
When no virus was detected at the 10-1 dilution, the titer was calculated 
1 E. Leitz Inc., Rockleigh, New Jersey. 
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as ~1.5 log10 TCID50/ml since virus could be present in one or more wells at 
the 10° dilution. 
Cytopathologic Effect 
After the slides were examined for fluorescence, they were then 
stained with May-Grunwald Giemsa stain and examined for cytopathology by 
light microscopy . The rubber gaskets attached to the slides were removed, 
and the slides were stained for 15 minutes at room temperature with May-
Grunwald stain. 1 The stain was removed by inverting the slides . The 
slides were then stained for 20 minutes with Giemsa stain2 diluted 1:15 in 
distilled water. The stain was removed by inverting the slides and 
rinsing them in distilled water for 10 to 20 seconds. The slides were air 
dried, and paraffin oil and coverslips were applied. 
Pock Formation in Eggs 
Seven-day old embryonated chicken eggs were used to titrate the CD 
viruses . The CAM was dropped by punching a hole in the air sac and then 
punching another hole in the side of the egg. Dilutions of the viruses 
were made in the tissue culture medium described previously, 10-1 through 
104 , and 0.1 ml of virus was inoculated into 4 eggs per dilution. The 
holes were sealed with glue, and the eggs were incubated at 35-37° C for 6 
days. At the end of the incubation period, the eggs were opened and the 
CAMs examined for plaques typical of CD (white to grayish-white plaque 
1 Harleco, Gibbstown, New Jersey. 
2 Fisher Scientific, Orangeburg, New York. 
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surrounded by an edematous area). The number of CAMs in each dilution 
showing plaques was recorded as the number of positive responses, and the 
50% endpoint of infection was calculated by the same method used for the 
tissue culture titrations . 
Infectivity of Field Isolates in Macrophages 
To determine if ferret alveolar macrophages would be an acceptable 
cell for the isolation of field strains of CD, the ability of the 5 field 
isolates from dogs to infect ferret alveolar macrophages was compared to 
the titers obtained for the viruses in canine alveolar macrophages and 
ferret peritoneal macrophages. The ferret alveolar macrophages were 
obtained and cultured using the techniques described for canine alveolar 
macrophages except that the cannula was inserted into the trachea .and both 
lungs were washed twice. 
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RESULTS AND DISCUSSION 
Replication in Tissue Culture 
The titers of the vaccine strains in tissue culture as determined by 
the fluorescent antibody technique are found in Table 2. As a group, the 
vaccine strains titered significantly lower (p <0.05) in canine alveolar 
macrophages than in primary canine kidney cells or Vero cells. 
Individually, the Rockborn and Lederle CFO strains titered lower in both 
canine alveolar macrophages and ferret peritoneal macrophages than in 
epithelial cells (primary canine kidney cells and Vero cells) . There was 
no appreciable difference in the titers obtained for the Snyder Hill 
strain and Lederle Vero cell origin (VCO) strain in macrophages and 
epithelial cells. Of interest is the finding that the Lederle CFO strain 
replicated in both primary canine kidney cells and Vero cells. The titers 
obtained in these two systems were 4.7 and 5.0 log10 tissue culture 
infective dose50 (TCID50)/ml respectively. The titer in eggs was 3.5 log10 
egg infectiye dose50/ml obtained when the virus was titered in eggs. 
All 4 of the field isolates from clinical canine distemper cases 
replicated in canine alveolar macrophages but no viral replication could 
be detected by the fluorescent antibody technique in primary canine kidney 
cells or Vero cells (Table 3). These findings were statistically 
significantly (p <0.01). Strain A76-30, obtained from a clinical case of 
old dog encephalitis was an exception. Titers of 2.5 log10 TCID50/ml in 
primary canine kidney cells and 3. 7 log10 TCID50/ml in Vero cells were 
obtained. 
38 
Appel (1978) took an avirulent canine kidney cell adapted 
Rockborn strain and passaged the virus in dogs to increase its virulence. 
He then compared the relative ability of the attenuated virus and the 
virulent virus to replicate in canine alveolar macrophages and canine 
kidney cells. The avirulent CD virus titered higher in canine kidney 
cells than in macrophages, while the virulent CD virus titered higher in 
macrophages than in canine kidney cells. 
Appel's results with the Rockborn strain were confirmed in this study 
for all strains tested. All avirulent vaccine strains titered 
significantly higher (p <0.05) in epithelial cells than in canine alveolar 
macrophages. The Rockborn, Snyder Hill, and Lederle CFO strains titered 
higher in primary canine kidney cells. The Vero adapted Lederle strain 
had a titer of 3.5 log10 TCID50/ml in canine macrophages and primary canine 
kidney cells, but it had a titer of 4.5 log10 TCID50/ml in Vero cells. 
All field isolates from clinical CD cases could be detected by the 
fluorescent antibody technique in canine alveolar macrophages but not in 
primary canine kidney cells . This is consistent with .Appel's finding that 
virulent Rockborn virus replicated to a higher titer in alveolar 
macrophages than primary canine kidney cells. Strain A76-30 obtained from 
a clinical case of old dog encephalitis grew in epithelial cells, but the 
titer was higher in canine alveolar macrophages. Growth in epithelial 
cells indicated that this strain may have been of vaccine origin. The 
fact that it now titered lower in epithelial cells than in macrophages 
after at least two passages in dogs is consistent with what Appel found 
with the Rockborn strain after it was passaged in dogs. Unlike the 4 
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Table 2. Viral titers8 of canine distemper vaccine strains in tissue 
culture 
Canine Ferret 
Strain alveolar peritoneal 
macrophage macrophage 
Rockborn 2.7 3.0 
Snyder Hill 3.7 4.5 
Leder le vcob 3.5 5.0 
Leder le CFOC 2.7 3.0 
8 Titers are expressed in log10 TCID50/ml. 
bvco Vero cell origin. 









Table 3. Viral titers8 of canine distemper field str ains in tissue 
culture 
Canine Ferret Primary 
Strain alveolar peritoneal canine Vero 
macrophage macrophage kidney 
Snyder Hill - NVSL 5.0 4.3 51. 5 51.5 
A75-17 4.3 2.3 51. 5 51.S 
A76 - 9 4.3 3.0 51. 5 51.S 
A76-21 3.0 1. 7 51.5 
A76-30 4. 5 5 . 0 2.5 3.7 
8Titers are expressed in log10 TCID50/ ml. 
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field strains from clinical CD, strain A76 -30 was not virulent for dogs 
when administered intravenously (Appel, 1989). 
'Whetstone et al. (1981) tested the virulent Snyder Hil l strain in 
various cell systems and reported that i t achieved the h ighest titer in 
ferret peritoneal macrophages . In the present study, the virulent Snyder 
Hill-NVSL strain along with 4 other fi e ld isolates were cultured in the 
macrophages and epithelial cells lis ted in Table 3. The results were 
consistent with those of 'Whetstone et al. (1981) in that the fie ld strains 
from clinical cases of canine distemper would replicate only in canine 
alveolar or ferret peri toneal macrophages. 
The virus titers of all vaccine strains tested in the study by 
'Whetstone et al. ( 1981) obtained in f erret peritoneal macrophages were 
equal to or higher than the titers obtained in canine kidney cells or 
eggs. The data presented in Table 2 show t hat t he Rockborn strain and the 
Lederle CFO strain achieved a higher titer in primary canine kidney cells 
than in ferret peritoneal macrophages (p <0.05). Consequently, the ferret 
peritoneal macrophage system is not the most sens itive tes t sys t em for 
titrating all vaccine strains of CD virus. 
As conc luded previously, the ability of a CD strain to grow in 
primary canine kidney cells or Vero cells appears to be a marker for 
differentiating field strains from vaccine strains. Vaccine strains wil l 
grow in epithelial cells while virulent field strains will not. 
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Cytopathologic Effect 
Inclusion body formation 
The 9 CD strains were inoculated into Vero cell cultures to determine 
if nuclear changes in those cells could be used to differentiate vaccine 
strains from field strains. The cultures were incubated for 6 days and 
then stained with fluorescein tagged CD antiserum. After the slides were 
examined for virus by the fluorescent antibody technique, they were 
staine d with May-Grunwald Giemsa stain and examined for inclusion bodies. 
There was no evidence of viral replication of the 4 field isolates from 
clinical cases of canine distemper when the cells were examined by e i ther 
the fluorescent antibody technique or May-Grunwald Giemsa stain . 
Confer et al. (197Sa) reported that virulent CD strains produced 
eosinophilic nuclear inclusion bodies in Vero cells while the avirulent 
Onderstepoort strain did not. However, the virulent strains used by 
Confer et al. (1975a) were not direct field isolates. They had been 
a dapted to tissue culture and had been passaged in Vero cells at leas t 5 
times. The isolates used in the present study were obtained directly from 
canine tissue and had not been passaged in cell culture. 
Based on the findings of t he present study, it can be concluded that 
the .ability to induce nuclear inclusion bodies in Vero cells is not an 
acceptable marker for virulent field viruses since these strains will not 
replicate sufficiently in Vero cells to form nuclear inclusion bodies 
without adaptation. 
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Giant cell formation 
Two distinct types of giant cells were observed in macrophage 
cultures inoculated with CDV . The first type was one in which the nuclei 
in the polykaryocytes were randomly arranged, highly pleomorphic and 
grossly distorted (Figure 1) . The second type was one in which the nuclei 
were uniform in size and positioned to form a ring around the outer edge 
of the giant cell which resembled a clockface (Figure 2). 
All the strains except the Rockborn and Snyder Hill vaccine strains 
produced giant cells in canine alveolar macrophages . The giant cell 
morphology observed is described in Table 4. Only the Lederle VCO vaccine 
strain and the Snyder Hill-NVSL and A76-17 field st~ains produced giant 
cells in ferret peritoneal macrophages. There was no correlation between 
the type of giant cell observed and the source of the strain. The giant 
cell type observed was not consistent with a specific strain . 
Poste (1971) described a giant cell in canine alveolar macrophages 
infected with virulent CDV that was identical to the irregular giant cell 
seen in this study. Ferret peritoneal macrophages infected with the same 
virus produced the "circular type giant cell similar to Figure 2. Only the 
circular type giant cell was described by Poste in canine alveolar 
macrophages and ferret peritoneal macrophages infected with the vaccine 
strain CDV/BW. 
Although Poste felt that there may be some significance to his 
finding that only v irulent virus would produce the irregular inclusion 
bodies in canine alveolar macrophages , there was no correlation between 
giant cell morphology and virulence with the larger number of strains used 
Figure 1. Irregular giant cell formation in canine alveolar 
macrophages infected with the CDV field isolate 




Figure 2. Circular giant cell formation in canine alveolar 
macrophages infected with GOV field i solate A76-21 
and stained with May -Grunwald Giemsa, x 400 
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Table 4. Comparison of vaccine and field strains by giant cell 
morphology8 in macrophages infected with canine distemper virus 
Canine Ferret 
Strain Source alveolar peritoneal 
macrophage macrophage 
Rockborn Vaccine None None 
Snyder Hill Vaccine None None 
Leder le vcob Vaccine Irregular Irregular 
Leder le CFOC Vaccine Irregular None 
Snyder Hill-NVSL Field Both Circular 
A75-17 Field Irregular Irregular 
A76-9 Field Circular None 
A76-21 Field Circular None 
A76-30 Field Both None 
8Irregular - nuclei in the giant cells were randomly arranged, highly 
pleomorphic and grossly distorted; circular - nuclei in the giant cells 
were uniform in size and positioned to form a ring around the outer edge 
of the cell; both - irregular and circular giant cells. 
t>vco - Vero cell origin. 
cCFO - Chicken fibroblast origin . 
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in the present study. It can be concluded, therefore, that giant cell 
morphology in canine alveolar macrophages is not a reliable marker to 
distinguish vaccine strains from field "strains . 
Pock Formation 
None of the S field strains used in the study would form pocks on 
CAMs of 7-day old embryonated chicken eggs. However, 3 of the 4 vaccine 
strains (Rockborn, Snyder Hill, Lederle VCO) would also not form pocks. 
Only the Lederle CFO strain produced pocks on CAMs. 
Hirayama et al. (1986) reported that attenuated canine distemper 
strains readily formed pocks on the chorioallantoic membranes while 
virulent CD strains did not. However, of the 7 attenuated strains that 
Hirayama et al. (1986) tested, all had been passaged in eggs at least 25 
times. None of the 3 virulent strains tested by Hirayama and colleagues 
had been passaged in eggs . Consequently, the ability to fo r m pocks on 
CAMs appears to be related to a history of passage in eggs and not to 
whether the strain was a vaccine or a field isolate. 
Infectivity of Field Isolates in Macrophages 
The 5 field isolates were titered in canine alveolar macrophages, 
ferret alveolar macrophages, and ferret peritoneal macrophages to 
determine which cell system was the most sensitive for the isolation of 
field strains. The r esults, shown in Table 5, demonstrate a higher 
infectivity in canine alveolar macrophages (mean of 4.22 log10 TCID50/ml) 
than ferret alveolar macrophages (mean of 2.42 log10 TCID.so/ml) or ferret 
peritoneal macrophages (mean of 3.26 log10 TCID50/ml) . The Snyder Hill-NVSL 
so 
strain ti tered 5. 0 log10 TCID50/ ml in the canine macrophages and 4. 3 log10 
TCID50/ml in ferret macrophages. This difference of only . 7 log10 TCID50/ ml 
may be due to the fact that it had been passaged previously in ferrets. 
The A76-30 isolate obtained a titer of 5.0 log10 TCID50/ ml in ferret 
peritoneal macrophages. This high titer is consistent with the previous 
results with the vaccine strains (Table 2) and indicate that this 
avirulent isolate may actually be of vaccine origin. 
The fluorescent antibody staining of field strains A75 -17, A76-9, and 
A76-30 was not as bright as the staining of the Snyder Hill-NVSL and 
A76-30 field strains. This weak fluorescence may be explained by the fact 
that the canine distemper antibody used to prepare the fluorescein 
conjugate was obtained from dogs administered vaccine strains and 
challenged with the virulent Snyder Hill-NVSL strain. Antigenic 
differences between the field strains and Snyder Hill-NVSL might result in 
a weaker fluorescence for the field strains because of a decrea-se in 
specific antigen-antibody binding. 
One reason for assaying the field strains in canine alveolar 
macrophages, ferret alveolar macrophages, and fer r et peritoneal 
macrophages was to determine if the cell type (alveolar vs. peritoneal) or 
the species of origin (canine vs. f erret) was contributing to the 
differences seen in the infectivity of the field strains in canine 
alveolar and ferret peritoneal macrophages. The results in Table S 
illustrate that the viral titers of t he field isolates obtained by the 
fluorescent antibody technique were significantly higher (p <0.05) in 
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Table 5. Viral titers3 of field strains of canine distemper 
virus in various macrophage systems 
Canine ·Ferret Ferret 
Strain alveolar alveolar peritoneal 
macrophage macrophage macrophage 
Snyder Hill-NVSL 5 . 0 4.0 4.3 
A75-17 4.3 1. 7 2.3 
A76-9 4.3 1. 7 3.0 
A76-21 3 . 0 1. 7 1. 7 
A76-30 4.5 3 . 0 5.0 
3 Ti ters are expressed in log10 TCID50/ ml. 
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canine alveolar cells than in ferret macrophages of either alveolar or 
peritoneal origin. The difference in titers between ferret alveol ar and 
ferret peritoneal macrophages was not significant (p >0.05). Therefore, 
the species of origin of the cells was the principal factor affecting 
viral replication . 
Whe tstone et al. (1981) concluded that ferret peritoneal macrophages 
could be used for isolating field virus and for the detection of CDV in 
tissues not suitable for frozen sections. This conclusion was based on 
information obtained with only t he Snyder Hill-NVSL strain. As ment ioned 
previously, canine alveolar macrophages were more sensitive to ferret 
peritoneal macrophages for the detection of the 4 field isolates from dogs 
·with clinical dis temper. Therefore, the use of fluorescent antibody 
techniques and fer ret peritoneal macrophages for the isolation of CDV may 
not be the preferred test system. The preferred test system would use 
canine alveolar macrophages to culture the isolate. The fluorescein 
tagged CD conjugate used should be prepared from a pool of sera from dogs 
infected with different field isolates. The use of a pool of sera may 
resul t in more intense staining if antigenic diversity is indeed the cause 
of the dim fluorescence seen when the field isolates were stained with 
conj ugate prepared from vaccine strains. 
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SUMMARY 
In this study, three methods of differentiating CDV field strains 
from vaccine strains were evaluated. They were comparisons of the ability 
of the strains to infect macrophages and epithelial cells as determined by 
the fluorescent antibody technique, evidence of giant cell formation in 
macrophages and nuclear inclusion bodies in Vero cells, and the ability of 
the strains to produce pocks on the chorioallantoic membrane of 
embryonated chicken eggs. 
Significant cytopathologic effect in macrophages did not correlate 
with strain origin. The field strains would not replicate in Vero cells 
so cytopathologic diffe rences in this cell type could not be determined. 
The ability of the strains to form pocks on CAMs did not correlate with 
virulence because the only isolate that formed pock s was a vaccine strain 
that had been passaged in eggs. The most reliable tes t method compared 
the ability of a strain to infect macroph ages and epithelial cells. Using 
the fluorescent antibody technique, vaccine strains replicated in 
epithelial cells and macrophages where as the field strains isolated from 
clinical cases of canine distemper w6uld only replicate at a detectable 
level (10~) in macrophages . 
Based on the findings and conclusions of this study, the following 
procedure is proposed for determining whether a case of clinical distempe r 
in a recently vaccinated dog was due to vaccine failure or caused by the 
vaccine itself . Tissues from the dog a re tite r e d in either canine 
alveolar macrophages or ferret peritoneal macrophages and in an epithelial 
cell such as canine kidney cells or Vero cells. Afte r incubating for 7 
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days, the cells are examined for specific viral fluorescence by the 
fluorescent antibody technique . If the isolate is of vaccine origin, it 
will be detected by the fluorescent antibody technique in both the 
macrophages and the epithelial cells . If the isolate is a field strain, 
it will only be detected in the macrophages. 
'When the 9 strains u tilized in this study were evaluated by the 
proposed technique, 4 of 4 vaccine strains grew in both cell types and 4 
of 4 virulent field strains would only grow on macrophages. The ninth 
strain, A76-30, obtained from a dog with old dog encepha litis grew in both 
types of cells . The ability of A76-30 to replicate in epithelial cells 
suggests that it was of vaccine or i gin ra ther than a true field strain 
capable of produc ing clinical distemper. 
'When comparing canin e alveolar , ferret alveolar, and ferre t 
peritoneal macrophages, the most sensitive cel l type for isolating field 
isolates was found to be canine alveolar macrophages. However, it is 
necessary to sacrifice a dog to obtain these cells. Since multiple 
harvests of peritoneal macrophages can be obtained from a ferret, fe rret 
peritoneal mac rophages may be preferred by some investigators wishing to 
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